Consumer Inertia and Firm Pricing in the Medicare Part D Prescription Drug Insurance Exchange

被引:88
|
作者
Ericson, Keith M. Marzilli [1 ]
机构
[1] Boston Univ, Boston, MA 02215 USA
关键词
SWITCHING COSTS; CHOICE; ELASTICITIES; COMPETITION; ADJUSTMENT; COVERAGE; MICRO;
D O I
10.1257/pol.6.1.38
中图分类号
F [经济];
学科分类号
02 ;
摘要
I use the Medicare Part D prescription drug insurance market to examine the dynamics of firm interaction with consumers on an insurance exchange. Enrollment data show that consumers face switching frictions leading to inertia in plan choice, and a regression discontinuity design indicates initial defaults have persistent effects. In the absence of commitment to future prices, theory predicts firms respond to inertia by raising prices on existing enrollees, while introducing cheaper alternative plans. The complete set of enrollment and price data from 2006 through 2010 confirms this prediction: older plans have approximately 10 percent higher premiums than comparable new plans.
引用
收藏
页码:38 / 64
页数:27
相关论文
共 50 条
  • [41] Health care fraud under the new medicare part D prescription drug program
    Rabecs, Robert N.
    JOURNAL OF CRIMINAL LAW & CRIMINOLOGY, 2006, 96 (02): : 727 - 756
  • [42] Medicare's New Part D Prescription Drug Benefit: A Major Work in Progress
    Bailes, Joseph
    JOURNAL OF ONCOLOGY PRACTICE, 2005, 1 (04) : 162 - 166
  • [43] Medicare quality improvement organizations' ambulatory drug therapy improvement activities and partnerships with Medicare Part D prescription drug plans and Medicare advantage plans
    Schulke, David G.
    Krantzberg, Elaine
    Grant, Jim
    JOURNAL OF MANAGED CARE PHARMACY, 2007, 13 (06): : S3 - S44
  • [44] Drug insurance and the strategic behavior of drug manufacturers: Evergreening and generic entry after Medicare Part D
    Sanzenbacher, Geoffrey T.
    Wettstein, Gal
    JOURNAL OF HEALTH ECONOMICS, 2020, 72
  • [45] The impact of Medicare part D prescription drug benefit program on generic drug prescription A study in long-term care facilities
    Jung, Changmi
    Padman, Rema
    Anwar, Shamena
    MEDICINE, 2019, 98 (32)
  • [46] Drug bills and Medicare part D
    Rodgers, J
    HEALTH AFFAIRS, 2005, 24 (06) : 1690 - 1690
  • [47] Medicare Part D and Changes in Prescription Drug Use and Cost Burden National Estimates for the Medicare Population, 2000 to 2007
    Briesacher, Becky A.
    Zhao, Yanfang
    Madden, Jeanne M.
    Zhang, Fang
    Adams, Alyce S.
    Tjia, Jennifer
    Ross-Degnan, Dennis
    Gurwitz, Jerry H.
    Soumerai, Stephen B.
    MEDICAL CARE, 2011, 49 (09) : 834 - 841
  • [48] Medicare Part D Prescription Drug Program: Benefits, Unintended Consequences and Impact on Health Disparities
    Clara E. Dismuke
    Leonard E. Egede
    Journal of General Internal Medicine, 2013, 28 : 860 - 861
  • [49] RELATIONSHIP BETWEEN DRUG COST COVERAGE AND PRESCRIPTION DECISION MAKING IN MEDICARE PART D ENROLLEES
    Hales, J. W.
    Dudley, S.
    Hegamin, A.
    Poulios, N.
    Mills, K.
    VALUE IN HEALTH, 2009, 12 (03) : A170 - A171
  • [50] Who Thinks That Part D Is Too Complicated? Survey Results on the Medicare Prescription Drug Benefit
    Cummings, Janet R.
    Rice, Thomas
    Hanoch, Yaniv
    MEDICAL CARE RESEARCH AND REVIEW, 2009, 66 (01) : 97 - 115